Abstract:Background: Results from randomized controlled trials (RCTs) comparing invasive and conservative strategies in patients with non-ST-elevation acute coronary syndrome (NSTE-ACS) are highly debatable. A comprehensive evaluation of the time-varied outcomes of the two strategies is therefore urgently needed.Methods: The RCTs for the invasive versus conservative treatment strategies were identified by searching PubMed, Cochrane Central Register of Controlled Trials, Embase and ClinicalTrials.gov. Trials data for studies that had a minimum of a 30-day follow-up time were included. We categorized the follow-up time into six different periods: ≤ 6 months, 1 year, 2 years, 3 years, 5 years, and ≥ 10 years. The time-varied outcomes were major adverse cardiovascular event (MACE), death, myocardial infarction (MI), rehospitalization, cardiovascular death, bleeding, in-hospital death, and in-hospital bleeding. Risk ratios (RRs) and 95% confidence intervals (CIs) were calculated. Findings: We included 30 articles of 17 RCTs involving 12,331 participants in this meta-analysis. We found that invasive strategy did not provide appreciable benefit for NSTE-ACS in terms of MACE, death, and cardiovascular death at all time points of follow-up compared with conservative strategy. Although there was a risk reduction in MI within 6 months (RR 0·80, 95%CI 0·68-0·94) for invasive strategy, no significant differences were found in other periods between the two strategies. The invasive strategy did reduce rehospitalization within 6 months (0·69, 0·52-0·90), 1 year (0·73, 0·63-0·86) and 2 years (0·77, 0·60-1·00). Of note, increased risk was observed for invasive strategy in bleeding within 6 months (1·81, 1·13-2·88) and in-hospital bleeding (2·17, 1·52-3·10). In subgroup analyses, the invasive strategy decreased MACE risk for patients ≥ 65 years and showed benefit for men. In other subgroups stratified according to diabetes, ST-segment deviation and baseline troponin levels, no significant differences were observed between the two strategies.Interpretation: Compared with conservative strategy, the invasive strategy appears not to improve prognosis in most endpoints for patents with NSTE-ACS, especially in long-term outcomes.Registration Details: This meta-analysis was registered at PROSPERO (CRD42021289579).Funding Information: This study was supported by National Natural Science Foundation of China (81930107 and 81825023). Declaration of Interests: We declare no competing interests.

The Studies of Risk Factors and Early Intervention in Patients with Acute Coronary Syndromes Without ST-segment Elevation

Characteristics, prognostic determinants of monocytes, macrophages and T cells in acute coronary syndrome: protocol for a multicenter, prospective cohort study

The Effect of Early Invasive Strategy on Early and Late Outcomes in High-Risk Non-St-segment Elevation Acute Coronary Syndromes

[The Changes of Electrocardiogram and Impact of Early Invasive Strategy in Patients with Acute Coronary Syndromes Without ST-segment Elevation].

Clinical Analysis of 373 Patients with Non-ST Elevation Acute Coronary Syndrome in a Teaching Hospital

Early Invasive Strategy For Non-St Elevation Acute Coronary Syndrome: A Meta-Analysis Of Randomized, Controlled Trials

Short-term and Long-Term Outcome of Early Invasive Therapy in Patients with Non-St-segment Elevation Acute Coronary Syndrome: a Meta-Analysis

Clinical Study on Early Risk Stratification in Non-ST-segment Elevation Acute Myocardial Infarction

Invasive Management Strategies And Antithrombotic Treatments In Patients With Non-St-Segment-Elevation Acute Coronary Syndrome In China Findings From The Improving Ccc Project (Care For Cardiovascular Disease In China)

Comparison Of Early And Delayed Invasive Strategies In Short-Medium Term Among Patients With Non-St Segment Elevation Acute Coronary Syndrome: A Systematic Review And Meta-Analysis

Efficacy and Safety of Serial Atorvastatin Load in Chinese Patients Undergoing Elective Percutaneous Coronary Intervention: Results of the ISCAP (intensive Statin Therapy for Chinese Patients with Coronary Artery Disease Undergoing Percutaneous Coronary Intervention) Randomized Controlled Trial

OUTCOMES OF INVASIVE STRATEGY TO PATIENTS WITH NON-ST-ELEVATION ACUTE CORONARY SYNDROMES

Timing of Early Invasive Intervention in Patients with Moderate to High Risk Acute Coronary Syndromes

Comprehensive Evaluation of Time-Varied Outcomes for Invasive and Conservative Strategies in Patients with NSTE-ACS: a Meta-Analysis of Randomized Controlled Trials

Long-term Prognosis of Patients with Acute Non-St-segment Elevation Myocardial Infarction Undergoing Different Treatment Strategies.

The Role of TIMI Risk Score in Risk Stratification in Patients with Acute Coronary Syndromes Without Persistent ST Elevation

Timing of angiography and outcomes in patients with non-ST-segment elevation myocardial infarction: Insights from the evaluation and management of patients with acute chest pain in China registry

Early Statin Therapy and In-Hospital Outcomes in Acute Coronary Syndrome Patients Presenting with Advanced Killip Class at Admission: Findings from the CCC-ACS Project

In-Hospital Mortality and Treatment in Patients With Acute Coronary Syndrome With and Without Standard Modifiable Cardiovascular Risk Factors: Findings From the CCC-ACS Project

Effects of percutaneous coronary intervention at different therapy time on patients at 70 years or elder with non-ST-elevation acute coronary syndrome in intermediate-risk

A Pilot Study of Prognostic Value of Non-Invasive Cardiac Parameters for Major Adverse Cardiac Events in Patients with Acute Coronary Syndrome Treated with Percutaneous Coronary Intervention